Otros idiomas Caribou Biosciences, Inc.

Acciones

CRBU

US1420381089

Mercado cerrado - Nasdaq Otros sitios de cotización 21:59:52 30/05/2024			Varia. Cinco días.	Varia. 1 de enero.
2,845 ^USD	-1,22 %		-5,48 %	-50,35 %

09/05	CARIBOU BIOSCIENCES, INC. : El Truist Securities continua con su recomendación de compra	ZM
07/05	Caribou Biosciences, Inc. presenta los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor Conferences	30/05
Caribou Biosciences : Cas12a chRDNA in vivo editing ASGCT 2024	10/05
Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update	07/05
Caribou Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05
Caribou Biosciences to Participate in Upcoming Investor Conferences	01/05
Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	24/04
Caribou Biosciences : CB-010 ANTLER Case Study iwCAR-T 2024	23/04
Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)	15/04
Caribou Biosciences : CB-012 IND-enabling preclinical data AACR 2024	09/04
Sector Update: Health Care Stocks Lean Higher Pre-Bell Friday	05/04
Caribou Gets FDA Clearance For Phase 1 Testing of CB-010 Cell Therapy in Lupus Patients	04/04
Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus	04/04
Caribou Biosciences, Inc. Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus	04/04
Poseida Therapeutics Appoints Syed Rizvi as Chief Medical Officer	25/03
50 aandelen om te beleggen in KI, gezondheid, mobiliteit en energie	23/03
50 titoli per investire in AI, salute, mobilità ed energia	22/03
50 Top-Aktien für Investitionen in KI, Gesundheit, Mobilität und Energie	22/03
50 valeurs pour investir dans l'IA, la Santé, la Mobilité et l'Energie	22/03
Caribou Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	11/03
Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	11/03

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Caribou Biosciences, Inc.

Acciones

CRBU

US1420381089

Otros idiomas

Filtros